Literature DB >> 8429288

A biomarker for the assessment of niacin nutriture as a potential preventive factor in carcinogenesis.

E L Jacobson1, M K Jacobson.   

Abstract

The study of protective cellular responses to DNA damage has led to the working hypothesis that optimal niacin nutriture is a preventive factor in cancer. Described here is the development of a biomarker for determining niacin status termed Niacin Number. The combination of this biomarker with diet and cancer epidemiology will allow evaluation of the possible role of this nutrient in cancer risk.

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8429288     DOI： 10.1111/j.1365-2796.1993.tb00649.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN： 0954-6820            Impact factor:   8.989


  5 in total

1.  Mapping the role of NAD metabolism in prevention and treatment of carcinogenesis.

Authors:  E L Jacobson; W M Shieh; A C Huang
Journal:  Mol Cell Biochem       Date:  1999-03       Impact factor: 3.396

2.  1H NMR Metabolomics Study of Metastatic Melanoma in C57BL/6J Mouse Spleen.

Authors:  Xuan Wang; Mary Hu; Ju Feng; Maili Liu; Jian Zhi Hu
Journal:  Metabolomics       Date:  2014-12       Impact factor: 4.290

Review 3.  Niacin: an old drug rejuvenated.

Authors:  Vaijinath S Kamanna; Shobha H Ganji; Moti L Kashyap
Journal:  Curr Atheroscler Rep       Date:  2009-01       Impact factor: 5.113

4.  Identification of gene expression signature modulated by nicotinamide in a mouse bladder cancer model.

Authors:  Seon-Kyu Kim; Seok-Joong Yun; Jiyeon Kim; Ok-Jun Lee; Suk-Chul Bae; Wun-Jae Kim
Journal:  PLoS One       Date:  2011-10-10       Impact factor: 3.240

5.  Nicotinamide inhibits vasculogenic mimicry, an alternative vascularization pathway observed in highly aggressive melanoma.

Authors:  Orit Itzhaki; Eyal Greenberg; Bruria Shalmon; Adva Kubi; Avraham J Treves; Ronnie Shapira-Frommer; Camilla Avivi; Rona Ortenberg; Eytan Ben-Ami; Jacob Schachter; Michal J Besser; Gal Markel
Journal:  PLoS One       Date:  2013-02-25       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.